Gunjan Khanna

Welcome.

You're listening to McKinsey on Healthcare Podcast.

If you're looking for insights into the issues that matter most in healthcare right now, you're in the right place.

Explore wide-ranging conversations with leaders, changemakers, innovators, and professionals who are at the heart of healthcare today.

My name is Gunjan Khanna.

I'm a senior partner at McKinsey & Company, and I lead globally their healthcare private equity practice.

Let's get started.

Today, I have the pleasure of joining a dear friend and one of the leaders in healthcare, Amanda Eisel, who is the Chief Executive Officer of Zealous, a healthcare financial services platform providing integrated healthcare cost management and payment solutions that connect together insurers, providers, and consumers.

Amanda has over 20-plus years of experience really working at the intersection of healthcare and technology and having been involved in creating and scaling multiple platforms, of course, Zealous, but previously Waystar, and has also been an operating partner at Bain Capital prior to joining Zealous.

Now, within Zealous, she's been instrumental in accelerating companies' growth across development and launch of industry-leading reference-based pricing systems to support employees, employers, and TPAs.

In addition,

A lot of innovation going on from healthcare analytics standpoint, translating provider rate disclosure data sets into digestible insights for the payers.

And in addition, several acquisitions, including Sapphire Digital, to offer one-of-a-kind digital consumer price navigation platform.

So lots going on, Amanda, at your front, as I see what Zealous is up to.

We wanted to get Amanda together with us today on the podcast to really talk about one of the areas that they've been doing a lot of work on, including specifically on price transparency.

Amanda, thank you for joining us today.

So you've had an immense amount of experience in working in different forms on healthcare technology, lots of different problems going on in healthcare.

Why pick up an area like price transparency?

As I think about from an audience standpoint, for somebody who's not close to price transparency, what do you think is an impact?

I really like you talking about the quality along with the cost data because it becomes quite important especially to think about health care and of course access is an important part of the of the puzzle as well.